Epizootic pertussis focus of hamadryad baboons

Epizootic pertussis focus of hamadryad baboons

The absence of an adequate experimental animal model makes difficult study of immunity against whooping cough and its pathogenesis. Experimental whooping cough reported by us earlier in pubescent non-human primates of the Old World was accompanied by specific clinical and laboratory marks in the abs...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. Yu. Medkova, G. I. Karataev, Z. V. Shevtsova, A. Z. Matua, E. G. Semin, A. A. Amichba, L. N. Sinyashina, I. G. Kondzariya, V. S. Barkaya, Z. Ya. Mikvabia, A. L. Gintsburg
Format:	Article
Language:	Russian
Published:	Journal Infectology 2015-11-01
Series:	Журнал инфектологии
Subjects:	pertussis bordetella pertussis bacteria natural contagion transmission of pertussis infection epizootic focus experimental challenge non-human primates of the old world genom equivalent pertussis antibodies
Online Access:	https://journal.niidi.ru/jofin/article/view/428
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Pertussis — An update for general practice
by: A. Madide, et al.
Published: (2006-05-01)

FEATURES OF GENOTYPiNG VARIABILITY OF STRAINS OF BORDETELLA PERTUSSIS ALLOCATED FROM PATIENTS WITH WHOOPING COUGH IN RUSSIA
by: V. A. Aleshkin, et al.
Published: (2012-09-01)

SUSCEPTIBILITY OF BORDETELLA PERTUSSIS STRAINS TO ANTIBACTERIAL PREPARATIONS
by: O. Yu. Borisova, et al.
Published: (2015-08-01)

Do not let perfect be the enemy of good: the current reality of Bordetella testing
by: Rebecca Yee
Published: (2025-01-01)

Immunogenicity of GamLPV, an intranasal live vaccine for pertussis prevention, in adult volunteers: a blind, randomised, placebo-controlled trial to optimise the method and schedule of administration
by: A. A. Lidzhieva, et al.
Published: (2025-04-01)

A Clinical Study of the Safety and Tolerability of Live Nasal Vaccines for the Prevention of Pertussis
by: A. Yu. Medkova, et al.
Published: (2021-02-01)

Pertactin deficiency of Bordetella pertussis: Insights into epidemiology, and perspectives on surveillance and public health impact
by: Ulrich Heininger, et al.
Published: (2024-12-01)

Pertussis vaccination in adults: a behavioral study of physicians from the US, France, and Germany
by: Donald Middleton, et al.
Published: (2024-11-01)

The 2024 resurgence of Bordetella pertussis in Brazil and a decade-long epidemiological overview
by: Nathália Mariana Santos Sansone, et al.
Published: (2025-05-01)

Incidence and severity of pertussis among hospitalized infants, Sarawak, Malaysia, 2015-2021
by: Anand Mohan, et al.
Published: (2024-09-01)

Structure of Population of Strains of the Bordetella pertussis in the Russia
by: O. Yu. Borisova, et al.
Published: (2016-08-01)

Seroepidemiological Assessment of Bordetella pertussis in Jahrom, Southern Iran: A Cross‐Sectional Study
by: Rahim Raufi, et al.
Published: (2025-02-01)

Safety, immunogenicity, and protective efficacy of the intranasal live pertussis vaccine GamLPV in an infant monkey model (<i>Papio hamadryas</i>)
by: D. T. Kubrava, et al.
Published: (2024-12-01)

Mucosal IgA Antibodies are Critical for Bacterial Clearance of Bordetella pertussis in the Baboon Model
by: Gaurav Chauhan, et al.
Published: (2025-06-01)

Prevalence of Pertactin-Deficient Bordetella pertussis Isolates, Slovenia
by: Alex-Mikael Barkoff, et al.
Published: (2024-11-01)

RETRACTED: The Mechanism of Pertussis Cough Revealed by the Mouse-Coughing Model
by: Yukihiro Hiramatsu, et al.
Published: (2022-04-01)

Pertussis resurgence: epidemiological trends, pathogenic mechanisms, and preventive strategies
by: Yaping Sheng, et al.
Published: (2025-07-01)

Comparison of the clinical and laboratory characteristics of pertussis or viral lower respiratory tract infections
by: Suna Selbuz, et al.
Published: (2019-09-01)

Immunological Protection of Individuals Aged 3 to 25 Years Against Pertussis: Regional Cross-Sectional Study
by: Diana V. Sutovskaya, et al.
Published: (2021-03-01)

Vaccine antigen-based genotyping of Bordetella pertussis by direct Sanger sequencing of clinical samples in Peru from 2018 to 2019
by: Eduardo Juscamayta-López, et al.
Published: (2025-06-01)

СLINICAL AND LABORATORY FEATURES OF PERTUSSIS IN INFANTS
by: L. V. Kramar, et al.
Published: (2018-07-01)

Immunization status of Iranian military recruits against Bordetella pertussis infection (whooping cough)
by: Morteza Izadi, et al.
Published: (2011-03-01)

Intranasal application of a bifunctional pertactin-RTX fusion antigen elicits protection of mouse airway mucosa against Bordetella pertussis colonization
by: Carlos Espinosa-Vinals, et al.
Published: (2025-04-01)

MODERNIZATION OF GENEOTIPING OF STRAINS B. PERTUSSIS
by: G. A. Ivashinnikova, et al.
Published: (2015-08-01)

A clinical study of the immunogenicity and protective potency of a live recombinant GamLPV vaccine for intranasal use for the prevention of whooping cough in adult volunteers
by: Alevtina A. Lidzhieva, et al.
Published: (2024-12-01)

Immunization with whole cell but not acellular pertussis vaccines primes CD4 TRM cells that sustain protective immunity against nasal colonization with Bordetella pertussis
by: Mieszko M. Wilk, et al.
Published: (2019-01-01)

Antibody avidity to pertussis toxin after acellular pertussis vaccination and infection
by: Aapo Knuutila, et al.
Published: (2023-12-01)

Influence of storage conditions on the toxicity of whole-cell pertussis vaccine in outbred mice
by: I. A. Alekseeva, et al.
Published: (2025-04-01)

How to improve pertussis vaccination in pregnancy: a European expert review
by: Adam Finn, et al.
Published: (2025-12-01)

Bordetella pertussis diagnosis in children under five years of age in the Regional Hospital of Cajamarca, Northern Peru
by: Juana del Valle-Mendoza, et al.
Published: (2015-11-01)

A highly conserved sRNA downregulates multiple genes, including a σ54 transcriptional activator, in the virulence mode of Bordetella pertussis
by: Minji Sim, et al.
Published: (2025-08-01)

Pre-Clinical Toxicity Study and Safety Assessment of Candidate Live Pertussis Vaccine for Intranasal Administration
by: L. N. Sinyashina, et al.
Published: (2019-01-01)

Exploiting subtractive genomics to identify novel drug targets and new immunogenic candidates against Bordetella pertussis: an in silico study
by: Mahshid Khazani Asforooshani, et al.
Published: (2025-05-01)

Economic burden of pertussis in children: A single-center analysis in Hangzhou, China
by: Yan Liu, et al.
Published: (2024-12-01)

Clinical characteristics of pertussis in infants and risk factors for respiratory support
by: Cui Liru, et al.
Published: (2025-12-01)

Development of a Method and a Scheme for the Use of a Live Recombinant Vaccine "GamLPV". Safety and Tolerability of Double Intranasal Vaccination of Healthy Adult Volunteers
by: G. I. Karataev, et al.
Published: (2022-09-01)

Seroprevalence of IgG antibodies against pertussis toxin in the Chinese population: A systematic review and meta-analysis
by: Yao Zhu, et al.
Published: (2024-12-01)

The incidence and clinical effects of Bordetella pertussis in children hospitalized with acute bronchiolitis
by: Emilya Efendiyeva, et al.
Published: (2020-10-01)

Severe pertussis complicated by pulmonary hypertension in a Moroccan infant: a case report
by: Mehdi Belhakim, et al.
Published: (2025-08-01)

Clinico-Epidemiological And Microbiological Evolution Of Pertussis
by: I. V. Babachenko
Published: (2014-09-01)